Human CTLA-4 antibodies and their uses
US7605238B2 · kind B2 · utility
122Cited by
70References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2001 |
| Grant date | Oct 20, 2009 |
| Priority date | — |
| Expiry date | Sep 7, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.